Rise and Shine: What you need to know before the ASX opens
Link copied to
On Stockhead today, why the best ASX IPOs are probably happening right now, ecommerce stocks expecting a cracker of a Christmas, and the other reasons behind Bitcoin’s latest rally.
If you’re into biotechs, this is a big deal. There are only two days left to register for AusBiotech’s Australia Biotech Invest & Partnering conference. The conference is a one-day investment event focused on trends in life sciences investment and is being held on Thursday, October 29.
The event will be delivered online October 29 and will be available on demand for 30 days post the conference. Retail and high net worth investors can register to attend for free using this link.
If you want to know more first, Derek Rose had this preview of the event, which will feature some of the biggest names in the Australian biotech industry and abroad.
The following companies are in trading halts and are expected to exit in the next couple of days:
Clinuvel Pharmaceutivals (ASX:CUV) – regulatory decision on SCENESSE
Dampier Gold (ASX:DAU) – exploration results
K2fly (ASX:K2F) – acquisition
E2 Metals (ASX:E2M) – drilling results
Protean Energy (ASX:POW) – capital raising
Trimantium GrowthOps (ASX:TGO) – ASX delisting
Openlearning (ASX:OLL) – capital raising
Gold: $US1,901.23 ($2,669.06) (+0.18%)
Silver: $US24.25 ($34.04) (-1.25%)
Oil (WTI): $US38.56 (-3.24%)
Oil (Brent): $US40.80 (-3.02%)
Coal: $US58.52 (+0.42%)
Iron 62pc Fe: $US116.50 (-0.43%)
AUD/USD: $US0.7123 (-0.18%)
Bitcoin: $US13,039.16 (+0.03%)
Buy now, pay later (BNPL) stocks are always a talking point, and readers took an interest in our summary of the latest piece of research from the bearish market analysts at UBS.
Also, be sure to check in at 10.15am each day for our daily 10 at 10 column — a summary of the top winners & losers at the ASX opening using live data.